ADX10059

DRUG3 trials

Sponsors

Addex Pharma S.A.

Conditions

Gastroesophageal RefluxMigraine

Phase 2

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

CompletedNCT00810485

Addex Pharma S.A.Gastroesophageal Reflux

Start: 2008-12-31Updated: 2012-07-16

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

CompletedNCT00820079

Addex Pharma S.A.Gastroesophageal Reflux

Start: 2008-12-31Target: 120Updated: 2009-12-24

ADX10059 Migraine Prevention Study

TerminatedNCT00820105

Addex Pharma S.A.Migraine

Start: 2008-12-31Target: 350Updated: 2009-12-24